| A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis HSA Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal ... New England Journal of Medicine 384 (12), 1113-1124, 2021 | 1473 | 2021 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 406 | 2020 |
| Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab F Martínez, P Nos, S Benlloch, J Ponce Inflammatory bowel diseases 7 (4), 323-326, 2001 | 207 | 2001 |
| Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression M Berenguer, V Aguilera, M Prieto, F San Juan, JM Rayón, S Benlloch, ... Journal of hepatology 44 (4), 717-722, 2006 | 193 | 2006 |
| Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C M Berenguer, A Palau, A Fernandez, S Benlloch, V Aguilera, M Prieto, ... Liver Transplantation 12 (7), 1067-1076, 2006 | 189 | 2006 |
| Development and validation of hepamet fibrosis scoring system–a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis J Ampuero, R Pais, R Aller, R Gallego-Durán, J Crespo, C García-Monzón, ... Clinical Gastroenterology and Hepatology 18 (1), 216-225. e5, 2020 | 175 | 2020 |
| De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? S Benlloch, M Berenguer, M Prieto, R Moreno, F San Juan, M Rayón, ... American Journal of Transplantation 4 (4), 596-604, 2004 | 156 | 2004 |
| Loss of IL‐7 receptor alpha‐chain (CD127) expression in acute HCV infection associated with viral persistence L Golden‐Mason, JR Burton Jr, N Castelblanco, J Klarquist, S Benlloch, ... Hepatology 44 (5), 1098-1109, 2006 | 142 | 2006 |
| The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity J Ampuero, R Aller, R Gallego‐Durán, JM Banales, J Crespo, ... Alimentary pharmacology & therapeutics 48 (11-12), 1260-1270, 2018 | 123 | 2018 |
| Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH J Ampuero, R Aller, R Gallego-Durán, J Crespo, JL Calleja, ... Journal of Hepatology 73 (1), 17-25, 2020 | 103 | 2020 |
| Effect of calcineurin inhibitors on survival and histologic disease severity in HCV‐infected liver transplant recipients M Berenguer, V Aguilera, M Prieto, F San Juan, JM Rayón, S Benlloch, ... Liver Transplantation 12 (5), 762-767, 2006 | 102 | 2006 |
| Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers M López-Riera, I Conde, G Quintas, L Pedrola, Á Zaragoza, ... Scientific reports 8 (1), 10606, 2018 | 86 | 2018 |
| Prediction of fibrosis in HCV‐infected liver transplant recipients with a simple noninvasive index S Benlloch, M Berenguer, M Prieto, JM Rayón, V Aguilera, J Berenguer Liver transplantation 11 (4), 456-462, 2005 | 73 | 2005 |
| Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients M Berenguer, V Aguilera, F San Juan, S Benlloch, A Rubin, ... Transplantation 90 (11), 1204-1209, 2010 | 72 | 2010 |
| Gastrointestinal complications in liver transplant recipients: MITOS study JI Herrero, S Benlloch, A Bernardos, I Bilbao, L Castells, JF Castroagudin, ... Transplantation proceedings 39 (7), 2311-2313, 2007 | 62 | 2007 |
| Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors F Piscaglia, A Cucchetti, S Benlloch, M Vivarelli, J Berenguer, L Bolondi, ... European journal of gastroenterology & hepatology 18 (12), 1255-1261, 2006 | 55 | 2006 |
| Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance C Pallarés, Â Carvalho-Gomes, V Hontangas, I Conde, T Di Maira, ... Journal of Clinical Virology 102, 77-83, 2018 | 46 | 2018 |
| Automated whole-liver MRI segmentation to assess steatosis and iron quantification in chronic liver disease D Martí-Aguado, A Jiménez-Pastor, Á Alberich-Bayarri, ... Radiology 302 (2), 345-354, 2022 | 41 | 2022 |
| Crohn’s disease and Sweet’s syndrome: an uncommon association I Catalán-Serra, L Martín-Moraleda, L Navarro-López, R Gil-Borrás, ... Rev Esp Enferm Dig 102 (5), 331-7, 2010 | 36 | 2010 |
| Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis F Pérez-Aguilar, JA Burguera, S Benlloch, M Berenguer, JM Rayón Journal of hepatology 42 (6), 947-949, 2005 | 36 | 2005 |
David Martí-AguadoServicio Medicina Digestiva Hospital Clínico Universitario de Valencia在 gva.es 的电子邮件经过验证
